Meta is diving into AI video generation with a splash. The company will work with and license models from Midjourney AI, one of the most popular AI image and video companies.Alexandr Wang, Meta's chief AI officer, revealed the partnership in a post on X Friday. It's still unclear when a possible Meta x Midjourney model could be available for people to use.Meta teased a possible tool, MovieGen, at its 2024 Connect event, but we haven't heard much since. Right now you can upload an existing file or image, or ...

The Chinese retailer posted an estimates-trouncing quarter.A strong quarterly earnings report was the rocket fuel sending Miniso's (MNSO 20.25%) American Depositary Shares (ADSs) more than 20% higher as the trading week came to a close Friday. The Chinese toy and home goods retailer notched convincing beats on both the top and bottom lines for the period, hence the excitement. By contrast, the S&P 500 index only managed a 1.5% gain. Not so mini these daysIn its second quarter, Miniso saw its revenue surge b ...

Anand Chokkavelu, CFA has no position in any of the stocks mentioned. Jason Hall has no position in any of the stocks mentioned. Matt Frankel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alexandria Real Estate Equities. The Motley Fool has a disclosure policy. ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Novo Nordisk A/S securities between May 7, 2025, and July 28, 2025, of the September 30, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Novo Nordisk securities during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by September 30, 2025, to serve as lead plaintiff [2] - The lawsuit alleges that defendants made misleading statements about Novo Nordisk's growth potential while concealing material adverse facts [4] Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been recognized for its performance in securities class action settlements [3] Group 3: Case Allegations - The lawsuit claims that Novo Nordisk overstated its growth potential and the likelihood of patients switching to its branded alternatives, leading to investor damages when the true information became public [4]

Core Insights - Mustang Energy Corp. has completed the first phase of field exploration activities on the Surprise Creek Uranium-Copper Project, acquiring an 80% interest through an option agreement with Thunderbird Resources Ltd. [1][2] Exploration Activities - The field program included surface prospecting and detailed rock sampling to refine target areas and outline mineralization [2] - Surface samples were collected from nine locations where previous uranium and copper mineralization was observed, with structural data collected from the Surprise Creek Fault area [2] Project Location and Historical Context - The Surprise Creek Project is located 25 km northwest of the Beaverlodge Uranium District, known for historical uranium mines [3] - A high-resolution airborne survey completed in September 2024 identified multiple new uranium targets in the area [4] Mineralization Findings - A strong uranium radiometric anomaly was identified at the Surprise Creek Fault drill target, with historical drilling returning results of up to 2.1m of 4.37% U3O8 from 57m [5] - Surface sampling returned assays up to 7.98% U3O8, with mineralization extending over a strike length of up to 500 m [5] Copper Prospects - The Project also contains historical copper prospects, with drilling results including 9.1m at 2.07% Cu and 27.3g/t Ag from surface at Bob Lake [7] - Rock chip sampling returned assays of up to 61.7% Cu, 27.6% Cu, and 9% Cu from historical copper occurrences [7] Regulatory Approvals - A work permit application for exploration, including drilling at the Surprise Creek Fault prospect, has been approved by the Saskatchewan Government [8] Company Overview - Mustang Energy is focused on discovering and developing high-potential uranium and critical mineral assets, holding a portfolio of 147,153 hectares in Saskatchewan's Athabasca Basin [17]

Group 1 - The timing of the opening pitch for Prosperity Bancshares (NYSE: PB) was not ideal, coinciding with a significant market event referred to as the "Liberation Day" tariff sell-off [1] - The company adopts a long-term, buy-and-hold investment strategy, focusing on stocks that can consistently deliver high-quality earnings, particularly in the dividend and income sectors [1] Group 2 - The article reflects the author's personal opinions and does not involve any compensation from the companies mentioned, indicating a lack of business relationships with those companies [2]

Group 1: Stock Performance - Morgan Stanley (MS) closed at $148.02, marking a +2.76% move from the prior day, outperforming the S&P 500's daily gain of 1.52% [1] - Over the previous month, shares of Morgan Stanley gained 1.08%, trailing the Finance sector's gain of 1.71% and the S&P 500's gain of 1.1% [1] Group 2: Earnings Projections - The upcoming EPS for Morgan Stanley is projected at $2.02, indicating a 7.45% increase compared to the same quarter of the previous year [2] - Revenue is expected to be $16.05 billion, reflecting a 4.33% increase compared to the year-ago quarter [2] - For the full year, earnings are projected at $8.82 per share and revenue at $66.86 billion, representing changes of +10.94% and +8.26% respectively from the prior year [3] Group 3: Analyst Estimates and Rankings - Recent changes in analyst estimates for Morgan Stanley reflect evolving short-term business trends, with positive revisions indicating analysts' confidence in business performance [4] - The Zacks Rank system, which considers estimate changes, currently ranks Morgan Stanley at 3 (Hold) [6] - Over the past month, the Zacks Consensus EPS estimate has shifted 0.41% upward [6] Group 4: Valuation Metrics - Morgan Stanley has a Forward P/E ratio of 16.34, which is a premium compared to the industry average Forward P/E of 16.27 [7] - The company holds a PEG ratio of 1.8, compared to the Financial - Investment Bank industry's average PEG ratio of 1.52 [8] Group 5: Industry Context - The Financial - Investment Bank industry is part of the Finance sector and currently has a Zacks Industry Rank of 7, placing it in the top 3% of all 250+ industries [8] - The strength of individual industry groups is measured by the Zacks Industry Rank, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [9]

Company Performance - Intuitive Surgical, Inc. (ISRG) closed at $476.16, with a +1.34% change from the previous day, lagging behind the S&P 500's 1.52% gain [1] - Over the previous month, ISRG shares experienced a loss of 3.83%, underperforming the Medical sector's gain of 4.77% and the S&P 500's gain of 1.1% [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $2, reflecting an 8.7% increase from the prior-year quarter, with revenue anticipated at $2.41 billion, indicating an 18.22% increase year-over-year [2] - For the entire year, the Zacks Consensus Estimates forecast earnings of $8.17 per share and revenue of $9.78 billion, representing changes of +11.31% and +17.1% compared to the previous year [3] Analyst Estimates and Valuation - Recent modifications to analyst estimates for ISRG suggest a changing business landscape, with positive revisions indicating confidence in performance and profit potential [4] - The Zacks Rank system, which considers estimate changes, currently ranks ISRG at 3 (Hold), with a recent upward shift of 3.59% in the EPS estimate [6] - ISRG has a Forward P/E ratio of 57.51, significantly higher than the industry average of 22.61, and a PEG ratio of 3.94 compared to the industry average PEG ratio of 2.26 [7] Industry Context - The Medical - Instruments industry, part of the Medical sector, has a Zacks Industry Rank of 153, placing it within the bottom 39% of over 250 industries [8]

Core Viewpoint - A securities class action lawsuit has been filed against Charter Communications, Inc. for allegedly making materially false and misleading statements regarding its business operations and the impact of the Affordable Connectivity Program cancellation on its performance [1][2]. Group 1: Allegations Against Charter - The lawsuit claims that Charter failed to disclose the significant impact of the cancellation of the Affordable Connectivity Program (ACP) on its Internet customer base and revenue [2]. - It is alleged that Charter's operational strategies were inadequate to mitigate the adverse effects of the ACP ending, leading to greater risks to business plans and earnings growth than previously reported [2]. - The complaint asserts that Charter's positive statements about its business and growth prospects were misleading and lacked a reasonable basis throughout the class period [2]. Group 2: Class Action Process - Investors in Charter have until October 14, 2025, to seek appointment as lead plaintiff in the class action, which involves representing the interests of all class members [3]. - The lead plaintiff is typically the investor or group of investors with the largest financial interest in the case and is responsible for directing the litigation [3]. - Participation as a lead plaintiff does not affect an investor's ability to share in any potential recovery from the lawsuit [3]. Group 3: Law Firm Information - Kessler Topaz Meltzer & Check, LLP is the law firm handling the class action and has a reputation for prosecuting class actions and recovering significant amounts for victims of corporate misconduct [4]. - The firm encourages Charter investors who have experienced losses to contact them for more information regarding the lawsuit [4].

Company Performance - JPMorgan Chase & Co. closed at $296.24, with a daily increase of +1.64%, outperforming the S&P 500's gain of 1.52% [1] - Over the past month, the company's shares experienced a decline of 1.71%, underperforming the Finance sector's gain of 1.71% and the S&P 500's gain of 1.1% [1] Upcoming Earnings - The company is projected to report earnings of $4.69 per share, reflecting a year-over-year growth of 7.32% [2] - Revenue is estimated at $43.91 billion, which is an increase of 2.95% from the prior-year quarter [2] Fiscal Year Estimates - For the entire fiscal year, earnings are expected to be $19.5 per share, indicating a decrease of -1.27% from the previous year [3] - Revenue for the fiscal year is projected at $177.19 billion, showing a slight decline of -0.21% from the prior year [3] Analyst Estimates - Recent modifications to analyst estimates indicate changing business trends, with positive revisions seen as a favorable sign for the business outlook [4] - The Zacks Rank system, which evaluates these estimate changes, currently ranks JPMorgan Chase & Co. as 1 (Strong Buy) [6] Valuation Metrics - The company has a Forward P/E ratio of 14.94, which is lower than the industry average Forward P/E of 16.27 [7] - The PEG ratio for JPMorgan Chase & Co. stands at 1.92, compared to the Financial - Investment Bank industry's average PEG ratio of 1.52 [7] Industry Context - The Financial - Investment Bank industry is part of the Finance sector and holds a Zacks Industry Rank of 7, placing it in the top 3% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]